CBD Life Sciences, Inc. (CBDL) Announces Expansion of Product Line
CBD Life Sciences (OTC PINK:CBDL) announces the launch of its new product, PR-X 100MG tablets, designed to support prostate health, urinary, and hair needs. The product features natural ingredients combined with high-quality Full-Spectrum CBD Isolate, and has undergone lab testing for potency. CEO Lisa Nelson highlights this launch as a significant step for the company, aimed at driving revenue growth and expanding market reach in Arizona. The press release also notes the extensive benefits of CBD for various health conditions.
- Launch of PR-X 100MG tablets expected to boost revenue.
- Product features all-natural ingredients and lab-tested quality.
- The new tablet targets multiple health issues, broadening potential consumer base.
- None.
SCOTTSDALE, AZ / ACCESSWIRE / November 9, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has developed a product that may aid consumers in many ways around the globe.
Our new PR-X 100MG per tablet supplement has been in development for several months and is finally ready to hit the shelves! This product has been created with all natural ingredients infused with the purest Full-Spectrum CBD Isolate on the market. It is also lab tested for potency and consistency. PR-X is designed for and may help with prostate health, urinary, & hair support. President & CEO Lisa Nelson states "This is a giant step in the right direction for the company as we are trying to always create new products that have never been seen before from any of our competitors. PR-X is expected to boost revenue significantly and we are currently contacting dispensaries & convenient stores around Arizona to push this specific product to the next level in a movement to promote overall health to the max!"
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to receive help from CBD. More updates to come!
LBC BIOSCIENCE INC. ONLINE STORE
LBC BIOSCIENCE'S Online Emporium
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top-selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
Become a Distributor
Large Selection of Products (over 50 items and growing)
All Products are THC-FREE (they contain
Weekly Deals (new deals every week)
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and bought on the Company's website at www.lbcbioscienceinc.com.
Ten Associates LLC
Contact:
Thomas E. Nelson
Telephone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/724654/CBD-Life-Sciences-Inc-CBDL-Announces-Expansion-of-Product-Line
FAQ
What is the new product announced by CBD Life Sciences (CBDL)?
How does PR-X 100MG support health according to the press release?
When was the new CBD product announced by CBDL?
What are the key ingredients of the PR-X 100MG tablets?